Research location
Teruel
Spain
Advertisement
Research activity in Teruel
SpainCureCurrent currently publishes aggregate city-level research activity for this location: 21 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Teruel
21 linked trials · page 1 of 1A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951 · 2023-03-31 · 1 site observation
RECRUITING
Unified Protocol for Bariatric Surgery CandidatesNCT04421443 · 2023-06-01 · 1 site observation
UNKNOWN
Smart Cupboard-based System for Memory Assessment in Alzheimer's PatientsNCT05202197 · 2021-10-30 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesNCT03882970 · 2019-04-01 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesNCT03495102 · 2018-04-05 · 1 site observation
COMPLETED
A Study of LY900014 in Participants With Type 1 DiabetesNCT03214367 · 2017-07-17 · 1 site observation
COMPLETED
Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseNCT02419872 · 2015-05-31 · 1 site observation
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesNCT02152371 · 2014-05-01 · 1 site observation
COMPLETED
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsNCT01723878 · 2013-12-30 · 1 site observation
COMPLETED
A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesNCT01790438 · 2013-03-01 · 1 site observation
COMPLETED
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer PatientsNCT01727427 · 2012-11-01 · 1 site observation
COMPLETED
A Study of LY2605541 in Participants With Type 2 Diabetes MellitusNCT01582451 · 2012-05-01 · 1 site observation
COMPLETED
Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing PatternsNCT01511926 · 2012-01-01 · 1 site observation
COMPLETED
A Study in Adults With Type 2 DiabetesNCT01421459 · 2011-09-01 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)NCT01191268 · 2010-11-01 · 1 site observation
COMPLETED
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusNCT01029795 · 2010-02-01 · 1 site observation
TERMINATED
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesNCT01029886 · 2010-01-01 · 1 site observation
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation
COMPLETED
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)NCT00641056 · 2008-04-01 · 1 site observation
COMPLETED
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and MetforminNCT00082407 · 2003-11-01 · 1 site observation
COMPLETED
PPAR-COMBO With SulfonylureaNCT00162175 · 2003-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.